February 22, 2024: Hemolysis, Icterus and Lipemia: New approaches to dealing with old foes

Group Photo Of Professional Colleagues Working Together In Clinical Analysis Laboratory
Clinical Chemist Working
Clinical Chemist Group
Clinical Chemist in Lab
Clinical Chemist in Lab
Clinical Chemist Group
Clinical Chemist Working on Computer
Clinical Chemist in Lab
Current Status
Not Enrolled
Price
Free
Get Started

Speaker:

Joe M. El-Khoury. Associate Professor of Laboratory Medicine at Yale School of Medicine and Director of the Clinical Chemistry Laboratory and fellowship program at Yale-New Haven Health.

Dr. Joe El-Khoury is Associate Professor of Laboratory Medicine at Yale School of Medicine and Director of the Clinical Chemistry Laboratory and fellowship program at Yale-New Haven Health. He is board certified by the American Board of Clinical Chemistry and a fellow of the Association for Diagnostics and Laboratory Medicine Academy. He currently serves on the Editorial Boards of Clinical Chemistry and Clinical Biochemistry , as Chair of the IFCC Committee on Kidney Diseases and on the Board of Directors for ADLM.

He recently launched his own Youtube channel, entitled “Clinical Chemistry with Joe El – Khoury”, that infuses science with comedy and is focused on improving laboratory medicine practice. His interests including reducing preanalytical errors, biomarkers of kidney disease and injury, toxicology, mass spectrometry and science communication.

Overview:

This lecture will describe the three most common types of interferences with clinical chemistry testing: hemolysis, icterus and lipemia. We will discuss the mechanism of interference for each, and more importantly, how clinical laboratories can implement new solutions to reduce or eliminate their effect.

Objectives:

At the conclusion of this session, participants will be able to:

  1. Describe the mechanisms of interference for hemolysis, icterus and lipemia (HIL).
  2. Identify new tools to reduce or eliminate the effects of HIL.